Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top

Drugs

Issue 14/2014

Content (11 Articles)

Echinocandin Resistance, Susceptibility Testing and Prophylaxis: Implications for Patient Management

  • Leading Article

David S. Perlin

Clinical Use of Rivaroxaban: Pharmacokinetic and Pharmacodynamic Rationale for Dosing Regimens in Different Indications

  • Open Access
  • Review Article

Toby Trujillo, Paul P. Dobesh

New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin®) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity

  • Open Access
  • Review Article

Mohamad Mohty, Andrea Bacigalupo, Faouzi Saliba, Andreas Zuckermann, Emmanuel Morelon, Yvon Lebranchu

Turning a Molecule into a Medicine: the Development of Indacaterol as a Novel Once-Daily Bronchodilator Treatment for Patients with COPD

  • Review Article

Lorraine Murphy, Stephen Rennard, James Donohue, Mathieu Molimard, Ronald Dahl, Kai-Michael Beeh, Juergen Dederichs, Hans-Jürgen Fülle, Mark Higgins, David Young

OnabotulinumtoxinA (Botox®): A Review of its Use in the Treatment of Urinary Incontinence in Patients with Multiple Sclerosis or Subcervical Spinal Cord Injury

  • Adis Drug Evaluation

Mark Sanford

Lanreotide Autogel®: A Review of its Use in the Treatment of Patients with Acromegaly

  • Adis Drug Evaluation

Celeste B. Burness, Sohita Dhillon, Susan J. Keam

Omalizumab: A Review of Its Use in Patients with Chronic Spontaneous Urticaria

  • Adis Drug Evaluation

Paul L. McCormack

Idelalisib: First Global Approval

  • R&D Insight Report

Anthony Markham

Ataluren: First Global Approval

  • R&D Insight Report

Nicola J. Ryan

Comment on “Treat-to-Target in Spondyloarthritis: Implications for Clinical Trial Designs”

  • Letter to the Editor

Daniel Wendling, Clément Prati

Author's Reply to Wendling and Prati: “Treat-to-Target in Spondyloarthritis: Implications for Clinical Trial Designs”

  • Letter to the Editor

James Cheng-Chung Wei

Sep 14
Issue: 13/2014
Oct 14
Issue: 15/2014

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images